2-201628160-TAAA-TA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001044385.3(TMEM237):c.870-13_870-12del variant causes a splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.0501 in 1,585,366 control chromosomes in the GnomAD database, including 2,367 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.067 ( 485 hom., cov: 31)
Exomes 𝑓: 0.048 ( 1882 hom. )
Consequence
TMEM237
NM_001044385.3 splice_polypyrimidine_tract, intron
NM_001044385.3 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.95
Genes affected
TMEM237 (HGNC:14432): (transmembrane protein 237) The protein encoded by this gene is a tetraspanin protein that is thought to be involved in WNT signaling. Defects in this gene are a cause of Joubert syndrome-14. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-201628160-TAA-T is Benign according to our data. Variant chr2-201628160-TAA-T is described in ClinVar as [Likely_benign]. Clinvar id is 257324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-201628160-TAA-T is described in Lovd as [Likely_benign]. Variant chr2-201628160-TAA-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM237 | NM_001044385.3 | c.870-13_870-12del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000409883.7 | NP_001037850.1 | |||
TMEM237 | NM_152388.4 | c.846-13_846-12del | splice_polypyrimidine_tract_variant, intron_variant | NP_689601.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM237 | ENST00000409883.7 | c.870-13_870-12del | splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_001044385.3 | ENSP00000386264 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0671 AC: 10204AN: 152114Hom.: 484 Cov.: 31
GnomAD3 genomes
AF:
AC:
10204
AN:
152114
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0428 AC: 9116AN: 212796Hom.: 279 AF XY: 0.0424 AC XY: 4858AN XY: 114564
GnomAD3 exomes
AF:
AC:
9116
AN:
212796
Hom.:
AF XY:
AC XY:
4858
AN XY:
114564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0483 AC: 69239AN: 1433136Hom.: 1882 AF XY: 0.0474 AC XY: 33704AN XY: 711262
GnomAD4 exome
AF:
AC:
69239
AN:
1433136
Hom.:
AF XY:
AC XY:
33704
AN XY:
711262
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0671 AC: 10211AN: 152230Hom.: 485 Cov.: 31 AF XY: 0.0648 AC XY: 4820AN XY: 74424
GnomAD4 genome
AF:
AC:
10211
AN:
152230
Hom.:
Cov.:
31
AF XY:
AC XY:
4820
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
63
AN:
3476
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 13, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 30, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Joubert syndrome 14 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Familial aplasia of the vermis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -11
Find out detailed SpliceAI scores and Pangolin per-transcript scores at